News/Reuters/隨著生物技術行業勢頭持續,Retension Pharmaceuticals和TRex Bio提交美國首次公開募股申請隨著生物技術行業勢頭持續,Retension Pharmaceuticals和TRex Bio提交美國首次公開募股申請Read the full articleGet unlimited access to articles from Reuters and every other news source on TradingView.Keep reading